PXS — Provexis Balance Sheet
0.000.00%
Last trade - 00:00- £15.31m
- £14.07m
- £1.29m
Annual balance sheet for Provexis, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1.08 | 0.864 | 0.379 | 0.189 | 0.708 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.05 | 0.117 | 0.122 | 0.158 | 0.079 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 1.29 | 1.13 | 0.846 | 0.498 | 1.01 |
| Total Assets | 1.29 | 1.13 | 0.846 | 0.498 | 1.01 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.151 | 0.158 | 0.188 | 0.307 | 0.248 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Liabilities | -0.363 | -0.372 | -0.344 | -0.226 | -0.294 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.66 | 1.5 | 1.19 | 0.724 | 1.3 |
| Total Liabilities & Shareholders' Equity | 1.29 | 1.13 | 0.846 | 0.498 | — |
| Total Common Shares Outstanding |